Credit Acceptance Announces Extension of Revolving Secured Line of Credit Facility
Southfield, Michigan, June 24, 2025 (GLOBE NEWSWIRE) — Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the 'Company', 'Credit Acceptance', 'we', 'our', or 'us') announced today that we have extended the maturity of our revolving secured line of credit facility with a commercial bank syndicate from June 22, 2027 to June 22, 2028.
As of June 24, 2025, we did not have a balance outstanding under the facility.
There were no other material changes to the terms of the facility.
Description of Credit Acceptance Corporation
We make vehicle ownership possible by providing innovative financing solutions that enable automobile dealers to sell vehicles to consumers regardless of their credit history. Our financing programs are offered through a nationwide network of automobile dealers who benefit from sales of vehicles to consumers who otherwise could not obtain financing; from repeat and referral sales generated by these same customers; and from sales to customers responding to advertisements for our financing programs, but who actually end up qualifying for traditional financing.
Without our financing programs, consumers are often unable to purchase vehicles or they purchase unreliable ones. Further, as we report to the three national credit reporting agencies, an important ancillary benefit of our programs is that we provide consumers with an opportunity to improve their lives by improving their credit score and move on to more traditional sources of financing. Credit Acceptance is publicly traded on the Nasdaq Stock Market under the symbol CACC. For more information, visit creditacceptance.com .
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Apple Is Going To Surprise Wall Street, Says Tom Lee, As iPhone Maker 'Could Be Quietly Ready To Pounce On AI'
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As Wall Street has been rallying behind the iPhone maker, led by Tim Cook, to dive into the artificial intelligence (AI) race, Fundstrat's Tom Lee says that Apple Inc. (NASDAQ:AAPL) could be ready to surprise investors. Check out the current price of AAPL stock here. What Happened: While a slew of opinions on Apple's acquisition of Perplexity AI make rounds on mainstream media and among top Wall Street experts, Lee's post on X highlights his belief in Apple's enduring strength and strategic timing in the market. He suggests that Apple is poised to make significant moves that could surprise investors. Trending: Tired of Grid Failures and Charging Deserts? This Startup Has a Solar Fix and $25M+ in Sales — In a snippet of his conversation with CNBC, reshared on X, Lee says, "For me, Apple has been quietly ready to pounce on AI. But I don't think they need to pay up for any of these models. So, I think Apple is going to surprise people."While Lee doesn't specifically vouch for Apple's acquisition of Perplexity AI, he seems confident that Cook to make a strategic move into AI. Meanwhile, Lee's peers Daniel Ives of Wedbush Securities and Jim Cramer have been urging the iPhone maker to acquire Peplexity. According to Bloomberg Opinion's U.S. technology columnist Dav Lee, Apple should continue its measured approach to building AI capabilities by hiring individual talent, rather than acquiring entire AI companies. He highlights that large acquisitions might seem tempting to quickly enhance Siri and other AI tools, but it carries significant risks of cultural clashes, operational hurdles, and regulatory It Matters: Cramer, in a recent X post had reiterated his views that "If Apple buys Perplexity, we would have our winning bot and the stock would soar." Cramer also calls out Apple on its buyback program and said that "Continued buybacks will do nothing." This comes as Apple spent the most on stock buybacks in recommendation is influenced by the U.S. government's antitrust ruling against Alphabet Inc.'s (NASDAQ:GOOG) (NASDAQ:GOOGL), expected by August, which may force Google to end default search deals with Apple's Safari browser. Similarly, Ives said at the beginning of July that Apple's 'treadmill approach' needs to end, and it needs to eye a big, splashing partnership with either Perplexity or Anthropic. 'Look, it's about the developers. If you look at OpenAI, if you look at Google, if you look at Microsoft, they (Apple) need to get into the game. That is something that can't be done in Cupertino,' he added. Read Next: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — And You Can Invest At Just $6.37/Share If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Image via Shutterstock This article Apple Is Going To Surprise Wall Street, Says Tom Lee, As iPhone Maker 'Could Be Quietly Ready To Pounce On AI' originally appeared on
Yahoo
15 minutes ago
- Yahoo
MicroStrategy (MSTR) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest close session, MicroStrategy (MSTR) was down 3.22% at $412.67. The stock's performance was behind the S&P 500's daily gain of 0.78%. Elsewhere, the Dow saw an upswing of 1.14%, while the tech-heavy Nasdaq appreciated by 0.61%. Coming into today, shares of the business software company had gained 13.1% in the past month. In that same time, the Computer and Technology sector gained 8.76%, while the S&P 500 gained 5.88%. Investors will be eagerly watching for the performance of MicroStrategy in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on July 31, 2025. It is anticipated that the company will report an EPS of -$0.12, marking a 84.21% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $112.15 million, indicating a 0.64% growth compared to the corresponding quarter of the prior year. For the full year, the Zacks Consensus Estimates are projecting earnings of -$15.73 per share and revenue of $466.5 million, which would represent changes of -134.08% and +0.66%, respectively, from the prior year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for MicroStrategy. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Our research shows that these estimate changes are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. MicroStrategy presently features a Zacks Rank of #3 (Hold). Investors should also note MicroStrategy's current valuation metrics, including its Forward P/E ratio of 58.41. This expresses a premium compared to the average Forward P/E of 24.84 of its industry. The Computer - Software industry is part of the Computer and Technology sector. At present, this industry carries a Zacks Industry Rank of 39, placing it within the top 16% of over 250 industries. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MicroStrategy Incorporated (MSTR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
28 minutes ago
- Yahoo
Nutex Health Responds to Short Seller Report
HOUSTON, July 23, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today provided the following response to a misleading short attack. The Company is aware of the allegations made in a recent short seller report that attempts to call into question the Company's collection process. As previously disclosed, Nutex Health has developed a robust internal process to code, bill and, if necessary after a federally mandated negotiation period, submit eligible medical claims to independent dispute resolution. The Company strongly disagrees with the allegations in the report and believes it is without merit. Further, the Company believes the report contains misrepresentations and conveys a misunderstanding of Nutex Health's business. Nutex Health expects to provide related updates in its upcoming earnings release and Form 10-Q for the second quarter of 2025 due on or before August 14, 2025. About Nutex Health Inc. Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Forward-Looking Statements Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2024, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. View original content: SOURCE Nutex Health, Inc. Sign in to access your portfolio
